BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9833633)

  • 1. Comparative effect of L-CCG-I, DCG-IV and gamma-carboxy-L-glutamate on all cloned metabotropic glutamate receptor subtypes.
    Brabet I; Parmentier ML; De Colle C; Bockaert J; Acher F; Pin JP
    Neuropharmacology; 1998 Aug; 37(8):1043-51. PubMed ID: 9833633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group II and III metabotropic glutamate receptors modulate paired pulse depression in the rat dentate gyrus in vitro.
    O'Leary DM; Cassidy EM; O'Connor JJ
    Eur J Pharmacol; 1997 Dec; 340(1):35-44. PubMed ID: 9527504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-CCG-I activates group III metabotropic glutamate receptors in the hippocampal CA3 region.
    Kirschstein T; von der Brelie C; Steinhäuser M; Vinçon A; Beck H; Dietrich D
    Neuropharmacology; 2004 Aug; 47(2):157-62. PubMed ID: 15223294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord.
    Ishida M; Saitoh T; Shimamoto K; Ohfune Y; Shinozaki H
    Br J Pharmacol; 1993 Aug; 109(4):1169-77. PubMed ID: 8401927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group II and group III metabotropic glutamate receptor agonists depress synaptic transmission in the rat spinal cord dorsal horn.
    Gerber G; Zhong J; Youn D; Randic M
    Neuroscience; 2000; 100(2):393-406. PubMed ID: 11008177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing conditions differentially affect the functional and structural properties of group-I and -II metabotropic glutamate receptors.
    Copani A; Romano C; Di Giorgi Gerevini V; Nicosia A; Casabona G; Storto M; Mutel V; Nicoletti F
    Brain Res; 2000 Jun; 867(1-2):165-72. PubMed ID: 10837810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of group II mGlu receptors inhibits voltage-gated Ca2+ currents in myenteric neurons.
    Chen WP; Kirchgessner AL
    Am J Physiol Gastrointest Liver Physiol; 2002 Dec; 283(6):G1282-9. PubMed ID: 12388194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 metabotropic glutamate (mGlu) receptors tonically inhibit transmitter release in rat caudate nucleus: in vivo studies with (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a new potent and selective antagonist.
    Cozzi A; Attucci S; Peruginelli F; Marinozzi M; Luneia R; Pellicciari R; Moroni F
    Eur J Neurosci; 1997 Jul; 9(7):1350-5. PubMed ID: 9240392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of group II metabotropic glutamate receptors in hippocampal CA1 long-term potentiation in vitro.
    Behnisch T; Wilsch VW; Balschun D; Reymann KG
    Eur J Pharmacol; 1998 Sep; 356(2-3):159-65. PubMed ID: 9774245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group II metabotropic glutamate receptor modulation of excitatory transmission in rat subthalamic nucleus.
    Shen KZ; Johnson SW
    J Physiol; 2003 Dec; 553(Pt 2):489-96. PubMed ID: 14500768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxicity of (2S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl)glycine, a potent agonist for class II metabotropic glutamate receptors, in the rat.
    Kwak S; Miyamoto M; Ishida M; Shinozaki H
    Neuroscience; 1996 Aug; 73(3):687-95. PubMed ID: 8809790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of Group I and Group II metabotropic glutamate receptor ligands on 5-hydroxytryptamine release in the rat cerebral cortex in vivo: differential roles in the regulation of central serotonergic neurotransmission.
    Lee JJ; Croucher MJ
    Neuroscience; 2003; 117(3):671-9. PubMed ID: 12617971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective metabotropic receptor agonists distinguish non-ionotropic glutamate binding sites.
    Testa CM; Hollingsworth ZR; Shinozaki H; Penney JB; Young AB
    Brain Res; 1997 Oct; 773(1-2):15-27. PubMed ID: 9409700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death.
    Bruno V; Copani A; Battaglia G; Raffaele R; Shinozaki H; Nicoletti F
    Eur J Pharmacol; 1994 Apr; 256(1):109-12. PubMed ID: 7517889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic glutamate receptor subtypes mediating slow inward tail current (IADP) induction and inhibition of synaptic transmission in olfactory cortical neurones.
    Libri V; Constanti A; Zibetti M; Postlethwaite M
    Br J Pharmacol; 1997 Mar; 120(6):1083-95. PubMed ID: 9134221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I- and II- selective metabotropic glutamate receptor agonists.
    Mistry R; Golding N; Challiss RA
    Br J Pharmacol; 1998 Feb; 123(3):581-9. PubMed ID: 9504400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
    Thomsen C; Bruno V; Nicoletti F; Marinozzi M; Pellicciari R
    Mol Pharmacol; 1996 Jul; 50(1):6-9. PubMed ID: 8700119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes.
    Cartmell J; Adam G; Chaboz S; Henningsen R; Kemp JA; Klingelschmidt A; Metzler V; Monsma F; Schaffhauser H; Wichmann J; Mutel V
    Br J Pharmacol; 1998 Feb; 123(3):497-504. PubMed ID: 9504391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Group II mGluRs in mossy fiber LTD.
    Wostrack M; Dietrich D
    Synapse; 2009 Dec; 63(12):1060-8. PubMed ID: 19637276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonist.
    Hanna L; Ceolin L; Lucas S; Monn J; Johnson B; Collingridge G; Bortolotto Z; Lodge D
    Neuropharmacology; 2013 Mar; 66():114-21. PubMed ID: 22445601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.